0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global mRNA Vaccine Core Enzyme Market Research Report 2026
Published Date: 2026-04-18
|
Report Code: QYRE-Auto-23Z13774
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global mRNA Vaccine Core Enzyme Market Research Report 2023
BUY CHAPTERS

Global mRNA Vaccine Core Enzyme Market Research Report 2026

Code: QYRE-Auto-23Z13774
Report
2026-04-18
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

mRNA Vaccine Core Enzyme Market Size

The global mRNA Vaccine Core Enzyme market was valued at US$ 1963 million in 2025 and is anticipated to reach US$ 1649 million by 2032, at a CAGR of -2.5% from 2026 to 2032.

mRNA Vaccine Core Enzyme Market

mRNA Vaccine Core Enzyme Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on mRNA Vaccine Core Enzyme competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
mRNA-vaccines can efficiently activate both components of the immune system, i.e., T-cell and humoral responses. The essential advantage of mRNA vaccines includes fast, inexpensive, scalable and uniform production providing a large output of desirable products in vitro. Synthesis and purification processes significantly simplify the process technology of mRNA drugs with injectable purity. Thus, mRNA production via in vitro transcription is more advantageous as compared with DNA-vaccines since it is a chemical process without the use of cells. mRNA techniques make it possible to pass all the phases of vaccine development much faster in comparison with the production of vaccines based on inactivated viruses or recombinant proteins. This property is critically important when designing vaccines against viral pathogens as the main problem of disease control includes a time gap between an epidemic and vaccine development. mRNA vaccine core enzyme is the key raw material in the production of mRNA vaccine and drugs.
The core manufacturers of mRNA Vaccine Core Enzyme mainly include Thermo Fisher, NEB, TriLink Bio Technologies, Merck, etc. The top four companies in the industry account for about 49% of the market. North America is the largest market, accounting for about 38% of the global market share. In terms of product type, Capping Enzyme have the largest market share of about 25%. From an application perspective, Biopharmaceutical Companies account for the largest share at around 84%.
This report delivers a comprehensive overview of the global mRNA Vaccine Core Enzyme market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding mRNA Vaccine Core Enzyme. The mRNA Vaccine Core Enzyme market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global mRNA Vaccine Core Enzyme market comprehensively. Regional market sizes by Enzyme Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist mRNA Vaccine Core Enzyme manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Enzyme Type, by Application, and by region.
Market Segmentation

Scope of mRNA Vaccine Core Enzyme Market Report

Report Metric Details
Report Name mRNA Vaccine Core Enzyme Market
Accounted market size in 2025 US$ 1963 million
Forecasted market size in 2032 US$ 1649 million
Base Year 2025
Forecasted years 2026 - 2032
Segment by Enzyme Type
  • Capping Enzyme
  • 2'-O-Methyltransferase
  • Inorganic Pyrophosphatase
  • Poly (A) Polymerase
  • Rnase Inhibitor
  • RNA Polymerase
  • Restriction Enzyme
  • Dnase I
  • Others
by Application
  • Biopharmaceutical Companies
  • Academic and Research Institutions
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher, NEB, TriLink Bio Technologies, Merck, Aldevron, Qiagen N.V., Promega, Roche CustomBiotech, Takara Bio Inc., Novoprotein, Vazyme, Hongene Biotech Corporatio, Yeasen Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Enzyme Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for mRNA Vaccine Core Enzyme manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines mRNA Vaccine Core Enzyme sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Enzyme Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

What is the mRNA Vaccine Core Enzyme Market size in 2032?

Ans: The mRNA Vaccine Core Enzyme Market size in 2032 will be US$ 1649 million.

What is the market share of major companies in mRNA Vaccine Core Enzyme Market?

Ans: The top four companies in the industry account for about 49% of the market.

What is the mRNA Vaccine Core Enzyme Market share by region?

Ans: North America is the largest market, accounting for about 38% of the global market share.

What is the mRNA Vaccine Core Enzyme Market share by type?

Ans: In terms of product type, Capping Enzyme have the largest market share of about 25%.

What is the mRNA Vaccine Core Enzyme Market share by application?

Ans: From an application perspective, Biopharmaceutical Companies account for the largest share at around 84%.

Who are the main players in the mRNA Vaccine Core Enzyme Market report?

Ans: The main players in the mRNA Vaccine Core Enzyme Market are Thermo Fisher, NEB, TriLink Bio Technologies, Merck, Aldevron, Qiagen N.V., Promega, Roche CustomBiotech, Takara Bio Inc., Novoprotein, Vazyme, Hongene Biotech Corporatio, Yeasen Biotechnology

What are the Application segmentation covered in the mRNA Vaccine Core Enzyme Market report?

Ans: The Applications covered in the mRNA Vaccine Core Enzyme Market report are Biopharmaceutical Companies, Academic and Research Institutions

What are the Type segmentation covered in the mRNA Vaccine Core Enzyme Market report?

Ans: The Types covered in the mRNA Vaccine Core Enzyme Market report are Capping Enzyme, 2'-O-Methyltransferase, Inorganic Pyrophosphatase, Poly (A) Polymerase, Rnase Inhibitor, RNA Polymerase, Restriction Enzyme, Dnase I, Others

1 mRNA Vaccine Core Enzyme Market Overview
1.1 Product Definition
1.2 mRNA Vaccine Core Enzyme by Enzyme Type
1.2.1 Global mRNA Vaccine Core Enzyme Market Value by Enzyme Type: 2025 vs 2032
1.2.2 Capping Enzyme
1.2.3 2'-O-Methyltransferase
1.2.4 Inorganic Pyrophosphatase
1.2.5 Poly (A) Polymerase
1.2.6 Rnase Inhibitor
1.2.7 RNA Polymerase
1.2.8 Restriction Enzyme
1.2.9 Dnase I
1.2.10 Others
1.3 mRNA Vaccine Core Enzyme by Application
1.3.1 Global mRNA Vaccine Core Enzyme Market Value by Application: 2025 vs 2032
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutions
1.4 Global mRNA Vaccine Core Enzyme Market Size Estimates and Forecasts
1.4.1 Global mRNA Vaccine Core Enzyme Revenue 2021–2032
1.4.2 Global mRNA Vaccine Core Enzyme Sales 2021–2032
1.4.3 Global mRNA Vaccine Core Enzyme Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 mRNA Vaccine Core Enzyme Market Competition by Manufacturers
2.1 Global mRNA Vaccine Core Enzyme Sales Market Share by Manufacturers (2021–2026)
2.2 Global mRNA Vaccine Core Enzyme Revenue Market Share by Manufacturers (2021–2026)
2.3 Global mRNA Vaccine Core Enzyme Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of mRNA Vaccine Core Enzyme, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of mRNA Vaccine Core Enzyme, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of mRNA Vaccine Core Enzyme, Product Types and Applications
2.7 Global Key Manufacturers of mRNA Vaccine Core Enzyme, Date of Entry into the Industry
2.8 Global mRNA Vaccine Core Enzyme Market Competitive Situation and Trends
2.8.1 Global mRNA Vaccine Core Enzyme Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global mRNA Vaccine Core Enzyme Players Market Share by Revenue
2.8.3 Global mRNA Vaccine Core Enzyme Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global mRNA Vaccine Core Enzyme Market Scenario by Region
3.1 Global mRNA Vaccine Core Enzyme Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global mRNA Vaccine Core Enzyme Sales by Region: 2021–2032
3.2.1 Global mRNA Vaccine Core Enzyme Sales by Region: 2021–2026
3.2.2 Global mRNA Vaccine Core Enzyme Sales by Region: 2027–2032
3.3 Global mRNA Vaccine Core Enzyme Revenue by Region: 2021–2032
3.3.1 Global mRNA Vaccine Core Enzyme Revenue by Region: 2021–2026
3.3.2 Global mRNA Vaccine Core Enzyme Revenue by Region: 2027–2032
3.4 North America mRNA Vaccine Core Enzyme Market Facts & Figures by Country
3.4.1 North America mRNA Vaccine Core Enzyme Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America mRNA Vaccine Core Enzyme Sales by Country (2021–2032)
3.4.3 North America mRNA Vaccine Core Enzyme Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe mRNA Vaccine Core Enzyme Market Facts & Figures by Country
3.5.1 Europe mRNA Vaccine Core Enzyme Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe mRNA Vaccine Core Enzyme Sales by Country (2021–2032)
3.5.3 Europe mRNA Vaccine Core Enzyme Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific mRNA Vaccine Core Enzyme Market Facts & Figures by Region
3.6.1 Asia Pacific mRNA Vaccine Core Enzyme Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific mRNA Vaccine Core Enzyme Sales by Region (2021–2032)
3.6.3 Asia Pacific mRNA Vaccine Core Enzyme Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America mRNA Vaccine Core Enzyme Market Facts & Figures by Country
3.7.1 Latin America mRNA Vaccine Core Enzyme Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America mRNA Vaccine Core Enzyme Sales by Country (2021–2032)
3.7.3 Latin America mRNA Vaccine Core Enzyme Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa mRNA Vaccine Core Enzyme Market Facts & Figures by Country
3.8.1 Middle East and Africa mRNA Vaccine Core Enzyme Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa mRNA Vaccine Core Enzyme Sales by Country (2021–2032)
3.8.3 Middle East and Africa mRNA Vaccine Core Enzyme Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Enzyme Type
4.1 Global mRNA Vaccine Core Enzyme Sales by Enzyme Type (2021–2032)
4.1.1 Global mRNA Vaccine Core Enzyme Sales by Enzyme Type (2021–2026)
4.1.2 Global mRNA Vaccine Core Enzyme Sales by Enzyme Type (2027–2032)
4.1.3 Global mRNA Vaccine Core Enzyme Sales Market Share by Enzyme Type (2021–2032)
4.2 Global mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2021–2032)
4.2.1 Global mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2021–2026)
4.2.2 Global mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2027–2032)
4.2.3 Global mRNA Vaccine Core Enzyme Revenue Market Share by Enzyme Type (2021–2032)
4.3 Global mRNA Vaccine Core Enzyme Price by Enzyme Type (2021–2032)
5 Segment by Application
5.1 Global mRNA Vaccine Core Enzyme Sales by Application (2021–2032)
5.1.1 Global mRNA Vaccine Core Enzyme Sales by Application (2021–2026)
5.1.2 Global mRNA Vaccine Core Enzyme Sales by Application (2027–2032)
5.1.3 Global mRNA Vaccine Core Enzyme Sales Market Share by Application (2021–2032)
5.2 Global mRNA Vaccine Core Enzyme Revenue by Application (2021–2032)
5.2.1 Global mRNA Vaccine Core Enzyme Revenue by Application (2021–2026)
5.2.2 Global mRNA Vaccine Core Enzyme Revenue by Application (2027–2032)
5.2.3 Global mRNA Vaccine Core Enzyme Revenue Market Share by Application (2021–2032)
5.3 Global mRNA Vaccine Core Enzyme Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Company Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher mRNA Vaccine Core Enzyme Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher mRNA Vaccine Core Enzyme Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 NEB
6.2.1 NEB Company Information
6.2.2 NEB Description and Business Overview
6.2.3 NEB mRNA Vaccine Core Enzyme Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 NEB mRNA Vaccine Core Enzyme Product Portfolio
6.2.5 NEB Recent Developments/Updates
6.3 TriLink Bio Technologies
6.3.1 TriLink Bio Technologies Company Information
6.3.2 TriLink Bio Technologies Description and Business Overview
6.3.3 TriLink Bio Technologies mRNA Vaccine Core Enzyme Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 TriLink Bio Technologies mRNA Vaccine Core Enzyme Product Portfolio
6.3.5 TriLink Bio Technologies Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck mRNA Vaccine Core Enzyme Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Merck mRNA Vaccine Core Enzyme Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Aldevron
6.5.1 Aldevron Company Information
6.5.2 Aldevron Description and Business Overview
6.5.3 Aldevron mRNA Vaccine Core Enzyme Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Aldevron mRNA Vaccine Core Enzyme Product Portfolio
6.5.5 Aldevron Recent Developments/Updates
6.6 Qiagen N.V.
6.6.1 Qiagen N.V. Company Information
6.6.2 Qiagen N.V. Description and Business Overview
6.6.3 Qiagen N.V. mRNA Vaccine Core Enzyme Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Qiagen N.V. mRNA Vaccine Core Enzyme Product Portfolio
6.6.5 Qiagen N.V. Recent Developments/Updates
6.7 Promega
6.7.1 Promega Company Information
6.7.2 Promega Description and Business Overview
6.7.3 Promega mRNA Vaccine Core Enzyme Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Promega mRNA Vaccine Core Enzyme Product Portfolio
6.7.5 Promega Recent Developments/Updates
6.8 Roche CustomBiotech
6.8.1 Roche CustomBiotech Company Information
6.8.2 Roche CustomBiotech Description and Business Overview
6.8.3 Roche CustomBiotech mRNA Vaccine Core Enzyme Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Roche CustomBiotech mRNA Vaccine Core Enzyme Product Portfolio
6.8.5 Roche CustomBiotech Recent Developments/Updates
6.9 Takara Bio Inc.
6.9.1 Takara Bio Inc. Company Information
6.9.2 Takara Bio Inc. Description and Business Overview
6.9.3 Takara Bio Inc. mRNA Vaccine Core Enzyme Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Takara Bio Inc. mRNA Vaccine Core Enzyme Product Portfolio
6.9.5 Takara Bio Inc. Recent Developments/Updates
6.10 Novoprotein
6.10.1 Novoprotein Company Information
6.10.2 Novoprotein Description and Business Overview
6.10.3 Novoprotein mRNA Vaccine Core Enzyme Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Novoprotein mRNA Vaccine Core Enzyme Product Portfolio
6.10.5 Novoprotein Recent Developments/Updates
6.11 Vazyme
6.11.1 Vazyme Company Information
6.11.2 Vazyme Description and Business Overview
6.11.3 Vazyme mRNA Vaccine Core Enzyme Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Vazyme mRNA Vaccine Core Enzyme Product Portfolio
6.11.5 Vazyme Recent Developments/Updates
6.12 Hongene Biotech Corporatio
6.12.1 Hongene Biotech Corporatio Company Information
6.12.2 Hongene Biotech Corporatio Description and Business Overview
6.12.3 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product Portfolio
6.12.5 Hongene Biotech Corporatio Recent Developments/Updates
6.13 Yeasen Biotechnology
6.13.1 Yeasen Biotechnology Company Information
6.13.2 Yeasen Biotechnology Description and Business Overview
6.13.3 Yeasen Biotechnology mRNA Vaccine Core Enzyme Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Yeasen Biotechnology mRNA Vaccine Core Enzyme Product Portfolio
6.13.5 Yeasen Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 mRNA Vaccine Core Enzyme Industry Chain Analysis
7.2 mRNA Vaccine Core Enzyme Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 mRNA Vaccine Core Enzyme Production Mode & Process Analysis
7.4 mRNA Vaccine Core Enzyme Sales and Marketing
7.4.1 mRNA Vaccine Core Enzyme Sales Channels
7.4.2 mRNA Vaccine Core Enzyme Distributors
7.5 mRNA Vaccine Core Enzyme Customer Analysis
8 mRNA Vaccine Core Enzyme Market Dynamics
8.1 mRNA Vaccine Core Enzyme Industry Trends
8.2 mRNA Vaccine Core Enzyme Market Drivers
8.3 mRNA Vaccine Core Enzyme Market Challenges
8.4 mRNA Vaccine Core Enzyme Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global mRNA Vaccine Core Enzyme Market Value by Enzyme Type (US$ Million), 2025 vs 2032
 Table 2. Global mRNA Vaccine Core Enzyme Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global mRNA Vaccine Core Enzyme Market Competitive Situation by Manufacturers in 2025
 Table 4. Global mRNA Vaccine Core Enzyme Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global mRNA Vaccine Core Enzyme Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global mRNA Vaccine Core Enzyme Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global mRNA Vaccine Core Enzyme Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market mRNA Vaccine Core Enzyme Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of mRNA Vaccine Core Enzyme, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of mRNA Vaccine Core Enzyme, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of mRNA Vaccine Core Enzyme, Product Types and Applications
 Table 12. Global Key Manufacturers of mRNA Vaccine Core Enzyme, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global mRNA Vaccine Core Enzyme Companies by Tier (Tier 1, Tier 2, Tier 3), based on mRNA Vaccine Core Enzyme Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global mRNA Vaccine Core Enzyme Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global mRNA Vaccine Core Enzyme Sales by Region (K Units), 2021–2026
 Table 18. Global mRNA Vaccine Core Enzyme Sales Market Share by Region (2021–2026)
 Table 19. Global mRNA Vaccine Core Enzyme Sales by Region (K Units), 2027–2032
 Table 20. Global mRNA Vaccine Core Enzyme Sales Market Share by Region (2027–2032)
 Table 21. Global mRNA Vaccine Core Enzyme Revenue by Region (US$ Million), 2021–2026
 Table 22. Global mRNA Vaccine Core Enzyme Revenue Market Share by Region (2021–2026)
 Table 23. Global mRNA Vaccine Core Enzyme Revenue by Region (US$ Million), 2027–2032
 Table 24. Global mRNA Vaccine Core Enzyme Revenue Market Share by Region (2027–2032)
 Table 25. North America mRNA Vaccine Core Enzyme Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America mRNA Vaccine Core Enzyme Sales by Country (K Units), 2021–2026
 Table 27. North America mRNA Vaccine Core Enzyme Sales by Country (K Units), 2027–2032
 Table 28. North America mRNA Vaccine Core Enzyme Revenue by Country (US$ Million), 2021–2026
 Table 29. North America mRNA Vaccine Core Enzyme Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe mRNA Vaccine Core Enzyme Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe mRNA Vaccine Core Enzyme Sales by Country (K Units), 2021–2026
 Table 32. Europe mRNA Vaccine Core Enzyme Sales by Country (K Units), 2027–2032
 Table 33. Europe mRNA Vaccine Core Enzyme Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe mRNA Vaccine Core Enzyme Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific mRNA Vaccine Core Enzyme Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific mRNA Vaccine Core Enzyme Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific mRNA Vaccine Core Enzyme Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific mRNA Vaccine Core Enzyme Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific mRNA Vaccine Core Enzyme Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America mRNA Vaccine Core Enzyme Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America mRNA Vaccine Core Enzyme Sales by Country (K Units), 2021–2026
 Table 42. Latin America mRNA Vaccine Core Enzyme Sales by Country (K Units), 2027–2032
 Table 43. Latin America mRNA Vaccine Core Enzyme Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America mRNA Vaccine Core Enzyme Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa mRNA Vaccine Core Enzyme Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa mRNA Vaccine Core Enzyme Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa mRNA Vaccine Core Enzyme Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa mRNA Vaccine Core Enzyme Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa mRNA Vaccine Core Enzyme Revenue by Country (US$ Million), 2027–2032
 Table 50. Global mRNA Vaccine Core Enzyme Sales (K Units) by Enzyme Type (2021–2026)
 Table 51. Global mRNA Vaccine Core Enzyme Sales (K Units) by Enzyme Type (2027–2032)
 Table 52. Global mRNA Vaccine Core Enzyme Sales Market Share by Enzyme Type (2021–2026)
 Table 53. Global mRNA Vaccine Core Enzyme Sales Market Share by Enzyme Type (2027–2032)
 Table 54. Global mRNA Vaccine Core Enzyme Revenue (US$ Million) by Enzyme Type (2021–2026)
 Table 55. Global mRNA Vaccine Core Enzyme Revenue (US$ Million) by Enzyme Type (2027–2032)
 Table 56. Global mRNA Vaccine Core Enzyme Revenue Market Share by Enzyme Type (2021–2026)
 Table 57. Global mRNA Vaccine Core Enzyme Revenue Market Share by Enzyme Type (2027–2032)
 Table 58. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Enzyme Type (2021–2026)
 Table 59. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Enzyme Type (2027–2032)
 Table 60. Global mRNA Vaccine Core Enzyme Sales (K Units) by Application (2021–2026)
 Table 61. Global mRNA Vaccine Core Enzyme Sales (K Units) by Application (2027–2032)
 Table 62. Global mRNA Vaccine Core Enzyme Sales Market Share by Application (2021–2026)
 Table 63. Global mRNA Vaccine Core Enzyme Sales Market Share by Application (2027–2032)
 Table 64. Global mRNA Vaccine Core Enzyme Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global mRNA Vaccine Core Enzyme Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global mRNA Vaccine Core Enzyme Revenue Market Share by Application (2021–2026)
 Table 67. Global mRNA Vaccine Core Enzyme Revenue Market Share by Application (2027–2032)
 Table 68. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Application (2021–2026)
 Table 69. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Application (2027–2032)
 Table 70. Thermo Fisher Company Information
 Table 71. Thermo Fisher Description and Business Overview
 Table 72. Thermo Fisher mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Thermo Fisher mRNA Vaccine Core Enzyme Product
 Table 74. Thermo Fisher Recent Developments/Updates
 Table 75. NEB Company Information
 Table 76. NEB Description and Business Overview
 Table 77. NEB mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. NEB mRNA Vaccine Core Enzyme Product
 Table 79. NEB Recent Developments/Updates
 Table 80. TriLink Bio Technologies Company Information
 Table 81. TriLink Bio Technologies Description and Business Overview
 Table 82. TriLink Bio Technologies mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. TriLink Bio Technologies mRNA Vaccine Core Enzyme Product
 Table 84. TriLink Bio Technologies Recent Developments/Updates
 Table 85. Merck Company Information
 Table 86. Merck Description and Business Overview
 Table 87. Merck mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Merck mRNA Vaccine Core Enzyme Product
 Table 89. Merck Recent Developments/Updates
 Table 90. Aldevron Company Information
 Table 91. Aldevron Description and Business Overview
 Table 92. Aldevron mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Aldevron mRNA Vaccine Core Enzyme Product
 Table 94. Aldevron Recent Developments/Updates
 Table 95. Qiagen N.V. Company Information
 Table 96. Qiagen N.V. Description and Business Overview
 Table 97. Qiagen N.V. mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Qiagen N.V. mRNA Vaccine Core Enzyme Product
 Table 99. Qiagen N.V. Recent Developments/Updates
 Table 100. Promega Company Information
 Table 101. Promega Description and Business Overview
 Table 102. Promega mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Promega mRNA Vaccine Core Enzyme Product
 Table 104. Promega Recent Developments/Updates
 Table 105. Roche CustomBiotech Company Information
 Table 106. Roche CustomBiotech Description and Business Overview
 Table 107. Roche CustomBiotech mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Roche CustomBiotech mRNA Vaccine Core Enzyme Product
 Table 109. Roche CustomBiotech Recent Developments/Updates
 Table 110. Takara Bio Inc. Company Information
 Table 111. Takara Bio Inc. Description and Business Overview
 Table 112. Takara Bio Inc. mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Takara Bio Inc. mRNA Vaccine Core Enzyme Product
 Table 114. Takara Bio Inc. Recent Developments/Updates
 Table 115. Novoprotein Company Information
 Table 116. Novoprotein Description and Business Overview
 Table 117. Novoprotein mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Novoprotein mRNA Vaccine Core Enzyme Product
 Table 119. Novoprotein Recent Developments/Updates
 Table 120. Vazyme Company Information
 Table 121. Vazyme Description and Business Overview
 Table 122. Vazyme mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Vazyme mRNA Vaccine Core Enzyme Product
 Table 124. Vazyme Recent Developments/Updates
 Table 125. Hongene Biotech Corporatio Company Information
 Table 126. Hongene Biotech Corporatio Description and Business Overview
 Table 127. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product
 Table 129. Hongene Biotech Corporatio Recent Developments/Updates
 Table 130. Yeasen Biotechnology Company Information
 Table 131. Yeasen Biotechnology Description and Business Overview
 Table 132. Yeasen Biotechnology mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Yeasen Biotechnology mRNA Vaccine Core Enzyme Product
 Table 134. Yeasen Biotechnology Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. mRNA Vaccine Core Enzyme Distributors List
 Table 138. mRNA Vaccine Core Enzyme Customers List
 Table 139. mRNA Vaccine Core Enzyme Market Trends
 Table 140. mRNA Vaccine Core Enzyme Market Drivers
 Table 141. mRNA Vaccine Core Enzyme Market Challenges
 Table 142. mRNA Vaccine Core Enzyme Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of mRNA Vaccine Core Enzyme
 Figure 2. Global mRNA Vaccine Core Enzyme Market Value by Enzyme Type (US$ Million), 2021–2032
 Figure 3. Global mRNA Vaccine Core Enzyme Market Share by Enzyme Type: 2025 & 2032
 Figure 4. Capping Enzyme Product Picture
 Figure 5. 2'-O-Methyltransferase Product Picture
 Figure 6. Inorganic Pyrophosphatase Product Picture
 Figure 7. Poly (A) Polymerase Product Picture
 Figure 8. Rnase Inhibitor Product Picture
 Figure 9. RNA Polymerase Product Picture
 Figure 10. Restriction Enzyme Product Picture
 Figure 11. Dnase I Product Picture
 Figure 12. Others Product Picture
 Figure 13. Global mRNA Vaccine Core Enzyme Market Value by Application (US$ Million), 2021–2032
 Figure 14. Global mRNA Vaccine Core Enzyme Market Share by Application: 2025 & 2032
 Figure 15. Biopharmaceutical Companies
 Figure 16. Academic and Research Institutions
 Figure 17. Global mRNA Vaccine Core Enzyme Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 18. Global mRNA Vaccine Core Enzyme Market Size (US$ Million), 2021–2032
 Figure 19. Global mRNA Vaccine Core Enzyme Sales (K Units), 2021–2032
 Figure 20. Global mRNA Vaccine Core Enzyme Average Price (US$/Unit), 2021–2032
 Figure 21. mRNA Vaccine Core Enzyme Report Years Considered
 Figure 22. mRNA Vaccine Core Enzyme Sales Share by Manufacturers in 2025
 Figure 23. Global mRNA Vaccine Core Enzyme Revenue Share by Manufacturers in 2025
 Figure 24. Top 5 and Top 10 Global mRNA Vaccine Core Enzyme Players: Market Share by Revenue in mRNA Vaccine Core Enzyme in 2025
 Figure 25. mRNA Vaccine Core Enzyme Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 26. Global mRNA Vaccine Core Enzyme Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 27. North America mRNA Vaccine Core Enzyme Sales Market Share by Country (2021–2032)
 Figure 28. North America mRNA Vaccine Core Enzyme Revenue Market Share by Country (2021–2032)
 Figure 29. United States mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Canada mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Europe mRNA Vaccine Core Enzyme Sales Market Share by Country (2021–2032)
 Figure 32. Europe mRNA Vaccine Core Enzyme Revenue Market Share by Country (2021–2032)
 Figure 33. Germany mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. France mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. U.K. mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Italy mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Russia mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Asia Pacific mRNA Vaccine Core Enzyme Sales Market Share by Region (2021–2032)
 Figure 39. Asia Pacific mRNA Vaccine Core Enzyme Revenue Market Share by Region (2021–2032)
 Figure 40. China mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Japan mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. South Korea mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. India mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Australia mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. China Taiwan mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Southeast Asia mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Latin America mRNA Vaccine Core Enzyme Sales Market Share by Country (2021–2032)
 Figure 48. Latin America mRNA Vaccine Core Enzyme Revenue Market Share by Country (2021–2032)
 Figure 49. Mexico mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Brazil mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Argentina mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Colombia mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Middle East and Africa mRNA Vaccine Core Enzyme Sales Market Share by Country (2021–2032)
 Figure 54. Middle East and Africa mRNA Vaccine Core Enzyme Revenue Market Share by Country (2021–2032)
 Figure 55. Turkey mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Saudi Arabia mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. UAE mRNA Vaccine Core Enzyme Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. Global Sales Market Share of mRNA Vaccine Core Enzyme by Enzyme Type (2021–2032)
 Figure 59. Global Revenue Market Share of mRNA Vaccine Core Enzyme by Enzyme Type (2021–2032)
 Figure 60. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Enzyme Type (2021–2032)
 Figure 61. Global Sales Market Share of mRNA Vaccine Core Enzyme by Application (2021–2032)
 Figure 62. Global Revenue Market Share of mRNA Vaccine Core Enzyme by Application (2021–2032)
 Figure 63. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Application (2021–2032)
 Figure 64. mRNA Vaccine Core Enzyme Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String